Gilead Sciences, Inc. is a company in the U.S. stock market and it is a holding in 235 U.S.-traded ETFs. GILD has around 114.9M shares in the U.S. ETF market. The largest ETF holder of GILD is the Invesco QQQ Trust (QQQ), with approximately 13.71M shares. Investors may also find of interest that the ETF with the largest allocation to GILD stock is iShares NASDAQ Biotechnology ETF (IBB), with a portfolio weight of 9.58%. On average, U.S. ETFs allocate 1.20% of GILD to their portfolios.
Additionally, GILD is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GILD as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.